ArticleAmerican journal of translational research2023
Association of ACP5 with the tumor immune microenvironment and its role in cell proliferation and metastasis in pancreatic cancer.
Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Differential contribution of TFE3 isoforms to cell motility and invasion.EMBO reports · 2026Article
- Transcriptomic profiling in canine B-cell lymphoma supports a synergistic effect of BTK and PI3K inhibitors.Frontiers in veterinary science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTartrate-resistant acid phosphatase (ACP5) has been implicated in the progression of most malignant tumors, but its role in pancreatic cancer (PC) remained unclear. Thus, this study aimed to elucidate the role and function of ACP5 in PC progression.
methodsThe expression of ACP5 in PC samples was assessed via R programming, TNM plot, and Gene Expression Profiling Interactive Analysis (GEPIA). Western blotting and immunohistochemistry (IHC) were performed to detect ACP5 expression in cells and tissues. The correlation between ACP5 and methylation was analyzed using the University of ALabama at Birmingham Cancer data analysis Portal (UALCAN) and cBio Cancer Genomics Portal (cBioPortal). The Database for Annotation, Visualization and Integrated Discovery (DAVID) and Gene Set Enrichment Analysis (GSEA) were used for the enrichment of ACP5 in PC. Subsequently, Cell Counting Kit-8 (CCK8), clonogenic, and wound healing assays were used to investigate the role of ACP5 in PC. Finally, Tumor Immune Estimation Resource (TIMER) and R programming was utilized in evaluating the association between ACP5 and immune cell infiltration in PC.
resultsThe analyses confirmed that ACP5 was highly expressed in PC samples. According to UALCAN and cBioPortal analysis, ACP5 expression, and methylation levels were negatively correlated in PC. The enrichment analysis also revealed that ACP5 was enriched in the proliferation and migration pathways. Meanwhile, ACP5 knockout reduced PC cell proliferation and migration and impaired the cells' independent viability. This gene also positively correlated with immune cell infiltration in PC, particularly regulatory T cells (Tregs).
conclusionACP5 is crucial for proliferation, migration, and immune cell infiltration in PC. Therefore, ACP5 may be a valuable target for future PC treatment.
Indexed as
Identifiers
38074824PMC10703664W4389801331What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.